- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
3
1 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
3 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
UTHR | US$367.97 | 0.9% | 69.0% | US$16.0b | US$398.00 | PE14.8x | E10.0% | n/a | ||
INVA | US$18.75 | 6.1% | 12.5% | US$1.2b | US$19.00 | PE18.2x | S4.3% | 0% | ||
DMTK.Q New | US$0.000001 | -99.8% | -100.0% | US$35.0 | n/a | PS0.000002x | n/a | n/a |
Page 1 of 1